(PharmaNewsWire.Com, July 13, 2017 ) In 2016, the world economy expanded by just 2.2 per cent, the slowest rate of growth since the Great Recession of 2009. Underpinning the sluggish global economy are the feeble pace of global investment, dwindling world trade growth, flagging productivity growth and high levels of debt. World gross product is forecast to expand by 2.7 per cent in 2017 and 2.9 per cent in 2018, with this modest recovery more an indication of economic stabilization than a signal of a robust and sustained revival of global demand. Given the close linkages between demand, investment, trade and productivity, the extended episode of weak global growth may prove self-perpetuating in the absence of concerted policy efforts to revive investment and foster a recovery in productivity. This would impede progress towards the Sustainable Development Goals (SDGs) , particularly the goals of eradicating extreme poverty and creating decent work for all.
Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Biosimilar Drug market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status.
Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross marBiosimilar Drug by regions (United States, EU, China, India and Japan) , and other regions can be added.
Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What's more, the Biosimilar Drug industry development trends and marketing channels are analyzed.
2 Industry market structure analysis 2.1 Supply & Consumption Analysis 2012-2017 2.1.1 North America 2.1.2 Europe 2.1.3 Japan 2.1.4 India 2.1.5 China
3 Industry market environment analysis 3.1 Industry requirements for resources and technology 3.2 Industry technology development trend 3.3 The impact of national macro policy on Industry 3.4 Other influencing factors
4 Competitive pattern analysis 4.1 Industry competitive structure analysis by Region 2012-2017 34 4.2 Industry competitive structure analysis by Manufacture 2012-2017 4.3 Market barriers to entry analysis 4.4 Threat of substitutes
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
